Back to funds

TCG Crossover Management, LLC

Updated 6 days ago

Managed by Tcg Crossover Management, Llc • Latest filing Q3 2026

Portfolio value
$3.5B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$3B
Q1 2026$3.5B
Q2 2026$4.2B
Q3 2026$3.5B

Top holdings

57 positions as of Q3 2026

View filing
A

ABIVAX SA AMERICAN DEPOSITARY SHARES

Value
$362.7M
Shares
3.66M
% Port
10.25%
C

CG ONCOLOGY INC

Value
$260.2M
Shares
3.67M
% Port
7.35%
A

AMYLYX PHARMACEUTICALS INC

Value
$181.7M
Shares
6.24M
% Port
5.13%
S

SPYRE THERAPEUTICS INC

Value
$169.2M
Shares
1.90M
% Port
4.78%
T

TANGO THERAPEUTICS INC

Value
$169M
Shares
6.77M
% Port
4.77%
Z

ZAI LAB LTD-ADR

Value
$164.1M
Shares
6.23M
% Port
4.64%
I

IMMUNOVANT INC

Value
$150.6M
Shares
4.46M
% Port
4.25%
D

DIANTHUS THERAPEUTICS INC

Value
$147.6M
Shares
1.68M
% Port
4.17%
K

KORSANA BIOSCIENCES INC

Value
$145.6M
Shares
4.55M
% Port
4.11%
K

KODIAK SCIENCES INC

Value
$137M
Shares
1.45M
% Port
3.87%
V

VOR BIOPHARMA INC

Value
$108.2M
Shares
5.67M
% Port
3.06%
T

FIRST TRACKS BIOTHERAPEUTICS

Value
$102.6M
Shares
2.90M
% Port
2.90%
M

MIRUM PHARMACEUTICALS INC

Value
$95.6M
Shares
1.12M
% Port
2.70%
B

BIOCRYST PHARMACEUTICALS INC

Value
$91.8M
Shares
11.02M
% Port
2.59%
I

DISC MEDICINE INC

Value
$87.8M
Shares
1.34M
% Port
2.48%
A

ADARX PHARMACEUTICALS INC

Value
$82.1M
Shares
4.12M
% Port
2.32%
C

COGENT BIOSCIENCES INC

Value
$80.1M
Shares
2.50M
% Port
2.26%
T

TYRA BIOSCIENCES INC

Value
$76M
Shares
3.48M
% Port
2.15%
D

DYNE THERAPEUTICS INC

Value
$74.3M
Shares
4.62M
% Port
2.10%
R

RELAY THERAPEUTICS INC

Value
$68.3M
Shares
3.78M
% Port
1.93%

Explore